vs
瑞思迈（RMD）与捷迈邦美（ZBH）财务数据对比。点击上方公司名可切换其他公司
捷迈邦美的季度营收约是瑞思迈的1.5倍（$2.1B vs $1.4B），瑞思迈净利率更高（27.6% vs 11.4%，领先16.2%），瑞思迈同比增速更快（11.0% vs 9.3%），瑞思迈自由现金流更多（$311.2M vs $245.9M），过去两年瑞思迈的营收复合增速更高（9.0% vs 3.7%）
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
捷迈邦美是一家美国上市的医疗设备企业，1927年成立，最初以生产铝制夹板为核心业务，总部设于印第安纳州华沙市，是当地医疗设备产业集群的核心成员，在全球骨科医疗器械领域拥有较高知名度。
RMD vs ZBH — 直观对比
营收规模更大
ZBH
是对方的1.5倍
$1.4B
营收增速更快
RMD
高出1.7%
9.3%
净利率更高
RMD
高出16.2%
11.4%
自由现金流更多
RMD
多$65.3M
$245.9M
两年增速更快
RMD
近两年复合增速
3.7%
损益表 — Q2 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $2.1B |
| 净利润 | $392.6M | $238.3M |
| 毛利率 | 61.8% | 64.6% |
| 营业利润率 | 34.6% | 17.9% |
| 净利率 | 27.6% | 11.4% |
| 营收同比 | 11.0% | 9.3% |
| 净利润同比 | 13.9% | 30.5% |
| 每股收益（稀释后） | $2.68 | $1.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RMDZBH
| Q1 26 | — | $2.1B | ||
| Q4 25 | $1.4B | $2.2B | ||
| Q3 25 | $1.3B | $2.0B | ||
| Q2 25 | $1.3B | $2.1B | ||
| Q1 25 | $1.3B | $1.9B | ||
| Q4 24 | $1.3B | $2.0B | ||
| Q3 24 | $1.2B | $1.8B | ||
| Q2 24 | $1.2B | $1.9B |
净利润RMDZBH
| Q1 26 | — | $238.3M | ||
| Q4 25 | $392.6M | $139.4M | ||
| Q3 25 | $348.5M | $230.9M | ||
| Q2 25 | $379.7M | $152.8M | ||
| Q1 25 | $365.0M | $182.0M | ||
| Q4 24 | $344.6M | $239.5M | ||
| Q3 24 | $311.4M | $249.1M | ||
| Q2 24 | $292.2M | $242.8M |
毛利率RMDZBH
| Q1 26 | — | 64.6% | ||
| Q4 25 | 61.8% | 64.7% | ||
| Q3 25 | 61.5% | 72.1% | ||
| Q2 25 | 60.8% | 71.5% | ||
| Q1 25 | 59.3% | 71.2% | ||
| Q4 24 | 58.6% | 71.0% | ||
| Q3 24 | 58.6% | 70.5% | ||
| Q2 24 | 58.5% | 71.5% |
营业利润率RMDZBH
| Q1 26 | — | 17.9% | ||
| Q4 25 | 34.6% | 6.9% | ||
| Q3 25 | 33.4% | 17.6% | ||
| Q2 25 | 33.7% | 14.4% | ||
| Q1 25 | 33.0% | 15.3% | ||
| Q4 24 | 32.5% | 19.2% | ||
| Q3 24 | 31.6% | 15.3% | ||
| Q2 24 | 31.2% | 18.1% |
净利率RMDZBH
| Q1 26 | — | 11.4% | ||
| Q4 25 | 27.6% | 6.2% | ||
| Q3 25 | 26.1% | 11.5% | ||
| Q2 25 | 28.2% | 7.4% | ||
| Q1 25 | 28.3% | 9.5% | ||
| Q4 24 | 26.9% | 11.8% | ||
| Q3 24 | 25.4% | 13.7% | ||
| Q2 24 | 23.9% | 12.5% |
每股收益（稀释后）RMDZBH
| Q1 26 | — | $1.22 | ||
| Q4 25 | $2.68 | $0.71 | ||
| Q3 25 | $2.37 | $1.16 | ||
| Q2 25 | $2.58 | $0.77 | ||
| Q1 25 | $2.48 | $0.91 | ||
| Q4 24 | $2.34 | $1.18 | ||
| Q3 24 | $2.11 | $1.23 | ||
| Q2 24 | $1.97 | $1.18 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $424.2M |
| 总债务越低越好 | $403.9M | $7.5B |
| 股东权益账面价值 | $6.3B | $12.7B |
| 总资产 | $8.5B | $22.7B |
| 负债/权益比越低杠杆越低 | 0.06× | 0.59× |
8季度趋势，按日历期对齐
现金及短期投资RMDZBH
| Q1 26 | — | $424.2M | ||
| Q4 25 | $1.4B | $591.9M | ||
| Q3 25 | $1.4B | $1.3B | ||
| Q2 25 | $1.2B | $556.9M | ||
| Q1 25 | $932.7M | $1.4B | ||
| Q4 24 | $521.9M | $525.5M | ||
| Q3 24 | $426.4M | $569.0M | ||
| Q2 24 | $238.4M | $420.1M |
总债务RMDZBH
| Q1 26 | — | $7.5B | ||
| Q4 25 | $403.9M | — | ||
| Q3 25 | $408.7M | — | ||
| Q2 25 | $658.4M | — | ||
| Q1 25 | $663.1M | — | ||
| Q4 24 | $662.9M | — | ||
| Q3 24 | $667.6M | — | ||
| Q2 24 | $697.3M | — |
股东权益RMDZBH
| Q1 26 | — | $12.7B | ||
| Q4 25 | $6.3B | $12.7B | ||
| Q3 25 | $6.1B | $12.8B | ||
| Q2 25 | $6.0B | $12.5B | ||
| Q1 25 | $5.5B | $12.4B | ||
| Q4 24 | $5.3B | $12.5B | ||
| Q3 24 | $5.2B | $12.4B | ||
| Q2 24 | $4.9B | $12.7B |
总资产RMDZBH
| Q1 26 | — | $22.7B | ||
| Q4 25 | $8.5B | $23.1B | ||
| Q3 25 | $8.3B | $23.5B | ||
| Q2 25 | $8.2B | $22.9B | ||
| Q1 25 | $7.6B | $22.2B | ||
| Q4 24 | $7.1B | $21.4B | ||
| Q3 24 | $7.2B | $21.7B | ||
| Q2 24 | $6.9B | $21.5B |
负债/权益比RMDZBH
| Q1 26 | — | 0.59× | ||
| Q4 25 | 0.06× | — | ||
| Q3 25 | 0.07× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.14× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $339.7M | $359.4M |
| 自由现金流经营现金流 - 资本支出 | $311.2M | $245.9M |
| 自由现金流率自由现金流/营收 | 21.9% | 11.8% |
| 资本支出强度资本支出/营收 | 2.0% | — |
| 现金转化率经营现金流/净利润 | 0.87× | 1.51× |
| 过去12个月自由现金流最近4个季度 | $1.8B | $1.4B |
8季度趋势，按日历期对齐
经营现金流RMDZBH
| Q1 26 | — | $359.4M | ||
| Q4 25 | $339.7M | $517.4M | ||
| Q3 25 | $457.3M | $418.7M | ||
| Q2 25 | $538.8M | $378.2M | ||
| Q1 25 | $578.7M | $382.8M | ||
| Q4 24 | $308.6M | $506.3M | ||
| Q3 24 | $325.5M | $395.7M | ||
| Q2 24 | $440.1M | $369.4M |
自由现金流RMDZBH
| Q1 26 | — | $245.9M | ||
| Q4 25 | $311.2M | $442.6M | ||
| Q3 25 | $414.4M | $363.7M | ||
| Q2 25 | $508.2M | $328.1M | ||
| Q1 25 | $557.9M | $338.2M | ||
| Q4 24 | $288.0M | $454.8M | ||
| Q3 24 | $307.7M | $351.2M | ||
| Q2 24 | $415.2M | $316.7M |
自由现金流率RMDZBH
| Q1 26 | — | 11.8% | ||
| Q4 25 | 21.9% | 19.7% | ||
| Q3 25 | 31.0% | 18.2% | ||
| Q2 25 | 37.7% | 15.8% | ||
| Q1 25 | 43.2% | 17.7% | ||
| Q4 24 | 22.5% | 22.5% | ||
| Q3 24 | 25.1% | 19.3% | ||
| Q2 24 | 33.9% | 16.3% |
资本支出强度RMDZBH
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | 3.3% | ||
| Q3 25 | 3.2% | 2.7% | ||
| Q2 25 | 2.3% | 2.4% | ||
| Q1 25 | 1.6% | 2.3% | ||
| Q4 24 | 1.6% | 2.5% | ||
| Q3 24 | 1.5% | 2.4% | ||
| Q2 24 | 2.0% | 2.7% |
现金转化率RMDZBH
| Q1 26 | — | 1.51× | ||
| Q4 25 | 0.87× | 3.71× | ||
| Q3 25 | 1.31× | 1.81× | ||
| Q2 25 | 1.42× | 2.48× | ||
| Q1 25 | 1.59× | 2.10× | ||
| Q4 24 | 0.90× | 2.11× | ||
| Q3 24 | 1.05× | 1.59× | ||
| Q2 24 | 1.51× | 1.52× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
ZBH
暂无分部数据
